研究總中心

Neuroscience

1. Alzheimer's Disease 71%
2. Amygdala 24%
3. Amyloid Protein 12%
4. Anterior Cingulate Cortex 9%
5. Antidepressant 17%
6. Anxiety Disorder 10%
7. Astrocyte 10%
8. Attention Deficit Hyperactivity Disorder 11%
9. Auras 8%
10. Basal Ganglia 8%
11. Behavior (Neuroscience) 38%
12. Bipolar Disorder 10%
13. Blood Plasma 21%
14. Brain Age 8%
15. Brain Areas 10%
16. Brain Disease 11%
17. Brain Ischemia 15%
18. Brain Network 24%
19. Brain-Computer Interface 14%
20. Brain-Derived Neurotrophic Factor 13%
21. Cerebellum 19%
22. Cerebrovascular Accident 36%
23. Cerebrovascular Disease 13%
24. Cingulate Cortex 9%
25. Cluster Headache 13%
26. Cognitive Disorders 40%
27. Cognitive Function 37%
28. Comorbidity 13%
29. Corpus Callosum 11%
30. Default Mode Network 17%
31. Depressive Disorder 14%
32. Diffusion Tensor Imaging 26%
33. Dopaminergic 10%
34. Electroencephalogram 40%
35. Epoxide Hydrolase 9%
36. Evoked Potential 8%
37. Executive Function 8%
38. Fibromyalgia 9%
39. Fluorine-18 15%
40. Fractional Anisotropy 16%
41. Frontal Lobe 14%
42. Functional Connectivity 71%
43. Functional Magnetic Resonance Imaging 63%
44. Gamma-Aminobutyric Acid 11%
45. Gene Expression 8%
46. Glutamic Acid 14%
47. Gray Matter 18%
48. Gray Matter Volume 35%
49. Gyri 13%
50. Headache 65%
51. Heart Rate Variability 25%
52. Hippocampus 32%
53. Hypertension 11%
54. In Vitro 12%
55. In Vivo 29%
56. Interneuron 9%
57. Ischemia 9%
58. Ketamine 10%
59. Longitudinal Study 16%
60. Magnetic Resonance Imaging 33%
61. Magnetic Resonance Imaging 31%
62. Magnetoencephalography 11%
63. Major Depressive Disorder 37%
64. Medication Overuse 11%
65. Mental Disorder 16%
66. Metabolic Pathway 8%
67. Migraine 100%
68. Mild Cognitive Impairment 32%
69. Mouse Brain 9%
70. Nervous System Disorder 11%
71. Neural Network 13%
72. Neural Stem Cell 10%
73. Neurodegenerative Disorder 10%
74. Neuronal Activity 8%
75. Neuronal Migration 9%
76. Neuroscience 8%
77. Nociception 13%
78. Obstructive Sleep Apnea 19%
79. Orbitofrontal Cortex 14%
80. Oxidative Stress 9%
81. Parkinson's Disease 31%
82. Pervasive Developmental Disorder 14%
83. Positron Emission Tomography 13%
84. Posterior Cingulate 9%
85. Precuneus 9%
86. Prefrontal Cortex 12%
87. Programmed Cell Death 11%
88. Putamen 11%
89. Rapid Eye Movement Sleep 8%
90. Receptor 19%
91. Sleep Disorder 8%
92. Sleep Quality 15%
93. Stem Cell 8%
94. Striatum 17%
95. Subjective Cognitive Decline 11%
96. Temporal Lobe 11%
97. Thalamus 21%
98. Tractography 16%
99. Transcranial Magnetic Stimulation 12%
100. Voxel-Based Morphometry 15%

Keyphrases

1. Age-related 13%
2. Aging 12%
3. Aging Effect 10%
4. Alzheimer's Disease 61%
5. Amygdala 15%
6. Anterior Cingulate Cortex 10%
7. Antidepressants 9%
8. Anxiety-depression 9%
9. Attention Deficit Hyperactivity Disorder 13%
10. Autism Spectrum Disorder 15%
11. Autonomic Dysfunction 9%
12. Bipolar Disorder 11%
13. Blood Pressure 9%
14. Brain Activity 11%
15. Brain Connectivity 10%
16. Brain Networks 12%
17. Brain Regions 27%
18. Brain Structure 10%
19. Brain-computer Interface 22%
20. Cerebellum 14%
21. Cerebral Small Vessel Disease (cSVD) 9%
22. Chronic Migraine 45%
23. Cluster Headache 18%
24. Cognitive Decline 13%
25. Cognitive Deficits 9%
26. Cognitive Function 32%
27. Cognitive Impairment 29%
28. Cognitive Performance 11%
29. Comorbidity 9%
30. Confidence Interval 23%
31. Cortex 9%
32. Default Mode Network 17%
33. Dementia 22%
34. Diffusion Tensor Imaging 22%
35. Electroencephalogram 18%
36. Electroencephalography 41%
37. Episodic Migraine 12%
38. Fractional Anisotropy 15%
39. Functional Connectivity 47%
40. Functional Magnetic Resonance Imaging 38%
41. Gray Matter Volume 36%
42. Hazard Ratio 11%
43. Headache 33%
44. Healthy Adults 10%
45. Healthy Controls 35%
46. Heart Rate Variability 20%
47. Hippocampus 22%
48. Human Brain 12%
49. Huntington's Disease 9%
50. Hypertension 10%
51. Induced Pluripotent Stem Cells (iPSCs) 10%
52. Insomnia 9%
53. Intracranial Hypotension 9%
54. Ischemic Stroke 11%
55. Ketamine 9%
56. Magnetic Resonance Imaging 20%
57. Magnetoencephalography 26%
58. Major Depressive Disorder 37%
59. Medication Overuse Headache 11%
60. Migraine 74%
61. Migraine Patients 20%
62. Mild Cognitive Impairment 26%
63. Mini-Mental State Examination 11%
64. MRI Study 10%
65. National Cohort Study 20%
66. Neural Correlates 9%
67. Neural Stem Cells 10%
68. Neurodegenerative Diseases 11%
69. Neuroimaging 15%
70. Obstructive Sleep Apnea 18%
71. Odds Ratio 11%
72. Older Adults 21%
73. Parkinson's Disease 28%
74. Pathophysiology 13%
75. Population-based Retrospective Cohort Study 9%
76. Positron Emission Tomography 13%
77. Protein Kinase 9%
78. Psychiatric Disorders 11%
79. Randomized Controlled Trial 9%
80. Rat Model 10%
81. Resting State 17%
82. Resting-state Functional Connectivity (rs-FC) 9%
83. Resting-state Functional Magnetic Resonance Imaging (rs-fMRI) 24%
84. Reversible Cerebral Vasoconstriction Syndrome 28%
85. Schizophrenia 35%
86. Schizophrenic Patients 11%
87. Single nucleotide Polymorphism 10%
88. Sleep Quality 12%
89. Soluble Epoxide Hydrolase 9%
90. Steady-state Visual Evoked Potential (SSVEP) 11%
91. Striatal 11%
92. Striatum 16%
93. Subjective Cognitive Decline 12%
94. Taiwan 54%
95. Taiwan Biobank 10%
96. Taiwanese 25%
97. Treatment-resistant Depression 9%
98. Voxel-based Morphometry 15%
99. White Matter 14%
100. White Matter Hyperintensities 11%